ClinicalTrials.gg
Drug

Prasugrel clinical trials

Also written Effient, Efient, LY640315 and CS-747.

studies test it
113
open now
7
in phase 3
29
first study started
2003

How each study uses prasugrel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the prasugrel studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
10 Jul 2009 · EFFIENT · NDA 022307 (FDA, Drugs@FDA)
European Union
24 Feb 2009 · Efient · EMEA/H/C/000984 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Prasugrel
81
Prasugrel 5mg
3
Prasugrel 5 mg
3
Prasugrel 60 mg
3
Prasugrel 10 mg
3

Brand

Effient
42
Efient
31
Effient 60 mg
2
Effient 5 mg
1
Effient 30 mg
1

Development codes

LY640315
20
CS-747
10

In one entry with another drug

Given together, or one or the other

Clopidogrel & Aspirin, Prasugrel & Aspirin
2

Studies by the year they started

113 studies that test it; most in 2011 (16)

Studies that test prasugrel, by start year
YearStudies
20031
20041
20062
20071
20082
200910
201015
201116
201214
201312
20148
20155
20162
20174
20186
20191
20203
20211
20223
20254
20262

By phase

A phase 1/2 study counts in both.

Phase 1
12
Phase 2
14
Phase 3
29
Phase 4
53
No phase
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 27 · Other 86

Eli Lilly and Company (20) · University of Florida (8) · University of Patras (7) · Dong-A University (5) · Daiichi Sankyo (3) · Gennaro Sardella (3) · Seoul National University Hospital (2) · Gyeongsang National University Hospital (2)

Often tested with

Tested in the same studies.

Ticagrelor (31) · Clopidogrel (25) · Aspirin (3) · Bivalirudin (2) · Selatogrel (1) · Cilostazol (1) · Ritonavir (1) · Abciximab (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test prasugrel.

Studies

Open first, then newest update. How each study uses prasugrel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 113

See all 113 studies that test prasugrel →

Given beside what is tested · 10 — prasugrel is usual care or a partner of the new treatment
As the comparator · 14 — what is tested is compared with prasugrel

Codes

What other systems call prasugrel · ClinicalTrials.gg INT006541

  • MeSH (NLM) D000068799Prasugrel HydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 34K66TBT99PRASUGRELConfirmed FDA, NLM, Wikidata
  • RxNorm 613391Confirmed FDA, Wikidata
  • Wikidata Q416232prasugrelConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C81566PrasugrelOne source FDA
  • DrugBank DB06209One source Wikidata

Also registered as prasugrel hydrochloride (UNII G89JQ59I13 · RxNorm 847020).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.